Bad Blood

Description

By John Carreyrou

Theranos was valued at nine billion dollars on the promise of running hundreds of blood tests from a single finger-prick. Elizabeth Holmes was on magazine covers, and the board included two former secretaries of state.

The technology did not work, and never had. Carreyrou, the Wall Street Journal reporter who broke the story, reconstructs how the deception was built and held together, and what happened to the employees who tried to raise it.

First published 2018